---
audienceLevel: patient
cancerTypes:
- breast
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- treatment
title: TAC - NCI
url: https://www.cancer.gov/about-cancer/treatment/drugs/tac
version: v1
---

# TAC - NCI

# TAC

This chemotherapy combination contains the drugs docetaxel (Taxotere), doxorubicin hydrochloride (Adriamycin), and cyclophosphamide. Combinations usually work better than single drugs because
different drugs kill
cancer
cells in different ways.

Drugs in the TAC combination:

|  |  |
| --- | --- |
| **T** | = [Docetaxel](/about-cancer/treatment/drugs/docetaxel) (Taxotere) |
| **A** | = [Doxorubicin Hydrochloride](/about-cancer/treatment/drugs/doxorubicinhydrochloride) (Adriamycin) |
| **C** | = [Cyclophosphamide](/about-cancer/treatment/drugs/cyclophosphamide) |

Each of the drugs in this combination is approved by the
[Food and Drug
Administration (FDA)](/Common/PopUps/popDefinition.aspx?id=454785&version=Patient&language=English)
to treat cancer or conditions related to cancer.

## Use in Cancer

TAC
is used to treat:

- **[Breast cancer](/Common/PopUps/popDefinition.aspx?id=444971&version=Patient&language=English).** It is often used as [adjuvant therapy](/Common/PopUps/popDefinition.aspx?id=45587&version=Patient&language=English).

This combination may also be used with other drugs or
treatments or to treat other types of cancer.

## More About TAC

[Definition from the NCI Drug Dictionary](https://www.cancer.gov/publications/dictionaries/cancer-drug/def/657046) - Detailed scientific definition and other names for this drug.
